Decoy Therapeutics Inc. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Decoy Therapeutics Inc. stock issued during period, value, issued for services for the quarter ending 2022-09-30 was $3.55K.
- Decoy Therapeutics Inc. stock issued during period, value, issued for services for the quarter ending 2022-06-30 was $25.00K.
- Decoy Therapeutics Inc. stock issued during period, value, issued for services for the quarter ending 2020-06-30 was $0.00.
- Decoy Therapeutics Inc. stock issued during period, value, issued for services for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- Decoy Therapeutics Inc. stock issued during period, value, issued for services for fiscal 2022 was $28.55K.
- Decoy Therapeutics Inc. stock issued during period, value, issued for services for fiscal 2020 was $50.00K, a 54.74% decline from fiscal 2019.
- Decoy Therapeutics Inc. stock issued during period, value, issued for services for fiscal 2019 was $110.47K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2022-12-31 | $28.55K 10-K · filed 2024-03-22 | |
| 2022-09-30 | $3.55K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $25.00K 10-Q · filed 2023-11-09 | |
| 2020-12-31 | $50.00K 10-K · filed 2022-03-25 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $110.47K 10-K · filed 2021-03-18 | |
| 2019-03-31 | $110.47K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |